366 related articles for article (PubMed ID: 23971052)
1. Correlations between psoriasis and inflammatory bowel diseases.
Skroza N; Proietti I; Pampena R; La Viola G; Bernardini N; Nicolucci F; Tolino E; Zuber S; Soccodato V; Potenza C
Biomed Res Int; 2013; 2013():983902. PubMed ID: 23971052
[TBL] [Abstract][Full Text] [Related]
2. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors.
Brophy S; Pavy S; Lewis P; Taylor G; Bradbury L; Robertson D; Lovell C; Calin A
J Rheumatol; 2001 Dec; 28(12):2667-73. PubMed ID: 11764216
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis and Inflammatory Bowel Disease.
Cottone M; Sapienza C; Macaluso FS; Cannizzaro M
Dig Dis; 2019; 37(6):451-457. PubMed ID: 31079092
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis and erythema nodosum: two comorbidities of inflammatory bowel diseases.
De Simone C; Sollena P; Coco V; Caldarola G
G Ital Dermatol Venereol; 2013 Apr; 148(2):175-84. PubMed ID: 23588143
[TBL] [Abstract][Full Text] [Related]
6. Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis.
Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Rizzello F; Gionchetti P
J Rheumatol; 2017 Sep; 44(9):1341-1346. PubMed ID: 28412702
[TBL] [Abstract][Full Text] [Related]
7. [Comorbidity in connection with psoriasis is more than psoriatic arthritis].
Kvist-Hansen A; Kaiser H; Skov L; Hansen PR
Ugeskr Laeger; 2018 Jan; 180(2):. PubMed ID: 29368688
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approach.
Hedin CRH; Sonkoly E; Eberhardson M; Ståhle M
J Intern Med; 2021 Aug; 290(2):257-278. PubMed ID: 33942408
[TBL] [Abstract][Full Text] [Related]
9. Global Prevalence and Bidirectional Association Between Psoriasis and Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.
Alinaghi F; Tekin HG; Burisch J; Wu JJ; Thyssen JP; Egeberg A
J Crohns Colitis; 2020 Mar; 14(3):351-360. PubMed ID: 31504363
[TBL] [Abstract][Full Text] [Related]
10. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
11. Genetics of spondyloarthritis--beyond the MHC.
Reveille JD
Nat Rev Rheumatol; 2012 Apr; 8(5):296-304. PubMed ID: 22487796
[TBL] [Abstract][Full Text] [Related]
12. Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study.
Lesuis N; Befrits R; Nyberg F; van Vollenhoven RF
BMC Med; 2012 Aug; 10():82. PubMed ID: 22853635
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis: new insight about pathogenesis, role of barrier organ integrity, NLR / CATERPILLER family genes and microbial flora.
Mattozzi C; Richetta AG; Cantisani C; Macaluso L; Calvieri S
J Dermatol; 2012 Sep; 39(9):752-60. PubMed ID: 22698089
[TBL] [Abstract][Full Text] [Related]
14. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
[TBL] [Abstract][Full Text] [Related]
15. [Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort].
Marín-Jiménez I; Gisbert JP; Pérez-Calle JL; García-Sánchez V; Tabernero S; García-Vicuña R; Romero C; Juliá B; Vanaclocha F; Cea-Calvo L;
Gastroenterol Hepatol; 2015 Dec; 38(10):569-74. PubMed ID: 25983283
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis: comorbidities and associations.
Farley E; Menter A
G Ital Dermatol Venereol; 2011 Feb; 146(1):9-15. PubMed ID: 21317853
[TBL] [Abstract][Full Text] [Related]
17. Cytokine network in psoriasis revisited.
Michalak-Stoma A; Pietrzak A; Szepietowski JC; Zalewska-Janowska A; Paszkowski T; Chodorowska G
Eur Cytokine Netw; 2011 Dec; 22(4):160-8. PubMed ID: 22236965
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease.
Eppinga H; Poortinga S; Thio HB; Nijsten TEC; Nuij VJAA; van der Woude CJ; Vodegel RM; Fuhler GM; Peppelenbosch MP
Inflamm Bowel Dis; 2017 Oct; 23(10):1783-1789. PubMed ID: 28617755
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric disorders in patients with immune-mediated inflammatory diseases: prevalence, association with disease activity, and overall patient well-being.
Walker JR; Graff LA; Dutz JP; Bernstein CN
J Rheumatol Suppl; 2011 Nov; 88():31-5. PubMed ID: 22045976
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of psoriasis.
Mahajan R; Handa S
Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S1-9. PubMed ID: 23974689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
